APA

Lanzillo R., Carbone F., Quarantelli M., Bruzzese D., Carotenuto A., De Rosa V., Colamatteo A., Micillo T., De Luca Picione C., Saccà F., De Rosa A., Moccia M., Brescia Morra V. & Matarese G. (20171213). Immunometabolic profiling of patients with multiple sclerosis identifies new biomarkers to predict disease activity during treatment with interferon beta-1a. : Clinical immunology (Orlando, Fla.).

Chicago

Lanzillo Roberta, Carbone Fortunata, Quarantelli Mario, Bruzzese Dario, Carotenuto Antonio, De Rosa Veronica, Colamatteo Alessandra, Micillo Teresa, De Luca Picione Carla, Saccà Francesco, De Rosa Anna, Moccia Marcello, Brescia Morra Vincenzo and Matarese Giuseppe. 20171213. Immunometabolic profiling of patients with multiple sclerosis identifies new biomarkers to predict disease activity during treatment with interferon beta-1a. : Clinical immunology (Orlando, Fla.).

Harvard

Lanzillo R., Carbone F., Quarantelli M., Bruzzese D., Carotenuto A., De Rosa V., Colamatteo A., Micillo T., De Luca Picione C., Saccà F., De Rosa A., Moccia M., Brescia Morra V. and Matarese G. (20171213). Immunometabolic profiling of patients with multiple sclerosis identifies new biomarkers to predict disease activity during treatment with interferon beta-1a. : Clinical immunology (Orlando, Fla.).

MLA

Lanzillo Roberta, Carbone Fortunata, Quarantelli Mario, Bruzzese Dario, Carotenuto Antonio, De Rosa Veronica, Colamatteo Alessandra, Micillo Teresa, De Luca Picione Carla, Saccà Francesco, De Rosa Anna, Moccia Marcello, Brescia Morra Vincenzo and Matarese Giuseppe. Immunometabolic profiling of patients with multiple sclerosis identifies new biomarkers to predict disease activity during treatment with interferon beta-1a. : Clinical immunology (Orlando, Fla.). 20171213.